CETIRIZINE HYDROCHLORIDE description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

CETIRIZINE HYDROCHLORIDE

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

OTC - ACTIVE INGREDIENT




OTC - PURPOSE



USES


  • ●     runny nose
  • ●     sneezing
  • ●     itchy, watery eyes
  • ●     itching of the nose or throat

WARNINGS



OTC - ASK DOCTOR



OTC - ASK DOCTOR/PHARMACIST



OTC - WHEN USING



OTC - STOP USE



OTC - PREGNANCY OR BREAST FEEDING



OTC - KEEP OUT OF REACH OF CHILDREN



DIRECTIONS




adults and children 6 years and over 1 to 2 tablets once daily; depending upon severity of symptoms; do not take more than 2 tablets in 24 hours
adults 65 years and over 1 tablet once a day; do not take more than 1 tablet in 24 hours
children under 6 years of age ask a doctor
consumers with liver or kidney disease ask a doctor

STORAGE AND HANDLING

  • ●     Store between 20 to 25 C (68 to 77 F)

INACTIVE INGREDIENT



HOW SUPPLIED



Cetirizine Hydrochloride Tablets, USP 5 mg  are supplied as white to off-white,square tablets, debossed “APO 5mg” on obverse and plain on the reverse.

They are available as follows:

Bottles of 100:   NDC 60505-2632-1


PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION













CETIRIZINE HYDROCHLORIDE

CETIRIZINE HYDROCHLORIDE

CETIRIZINE HYDROCHLORIDE

CETIRIZINE HYDROCHLORIDE TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-088(NDC:60505-2632)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
CETIRIZINE HYDROCHLORIDE CETIRIZINE 5 mg

Inactive Ingredients

Ingredient Name Strength
STARCH, CORN
HYPROMELLOSES
lactose monohydrate
MAGNESIUM STEARATE
povidone
titanium dioxide
polyethylene glycol

Product Characteristics

Color Size Imprint Code Shape
white 6 mm APO;5 SQUARE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-088-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA078317 2010-11-23


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.